Glyburide
Product Images NDC 68071-3493

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 68071-3493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3493 0)

Pdp (68071 3493 0)
The image shows a pharmaceutical label for GlyBURIDE 5 mg tablets, 100 count, manufactured by Cadila Pharmaceuticals Limited, India and marketed by NuCare Pharmaceuticals, Inc. The label includes dosage instructions and warnings, an NDC code 68071-3493-0, and indicates prescription use only. Storage recommendations and regulatory information are also present.*
FDA Label Image

Glyburide-fig-1 (Glyburide Fig 1)

Glyburide-fig-1 (Glyburide Fig 1)
Chemical structure of glyburide, showing its molecular arrangement with distinctive functional groups including a chlorobenzene ring, methoxy group, sulfonylurea moiety, and cyclohexylamino group, as provided by NuCare Pharmaceuticals' product labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.